Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation

Gastroenterology

Volumn 140, Issue 5, 2011, Pages

  Foley, Stephen ^a   Garsed, Klara ^a   Singh, Gulzar ^a,b   Duroudier, Nathalie P ^b   Swan, Caroline ^b   Hall, Ian P ^b   Zaitoun, Abed ^c   Bennett, Andrew ^b   Marsden, Charles ^b   Holmes, Geoffrey ^d   Walls, Andrew ^e   Spiller, Robin C ^a,c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d ROYAL DERBY HOSPITAL   (United Kingdom)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

5 Hydroxytryptamine Receptor; Enteroendocrine; Neurotransmitter; Serotonin

Indexed keywords

MESSENGER RNA; PAROXETINE; SEROTONIN TRANSPORTER; TRYPTASE;

ADULT; ARTICLE; BLOOD SAMPLING; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; DUODENUM MUCOSA; ENTEROCHROMAFFIN CELL; FEMALE; HISTOPATHOLOGY; HUMAN; IRRITABLE COLON; IRRITABLE COLON WITH DIARRHEA; LYMPHOCYTE; MALE; MAST CELL; MEMBRANE BINDING; MUCOSAL INTRAEPITHELIAL LYMPHOCYTE; PRIORITY JOURNAL; SEROTONIN UPTAKE; THROMBOCYTE; THROMBOCYTE MEMBRANE;

EID: 79955383575     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.01.052     Document Type: Article

References (50)

1. G.F. Longstreth, W.G. Thompson, and W.D. Chey Functional bowel disorders Gastroenterology 130 2006 1480 1491
2. M. Camilleri, W.Y. Chey, and E.A. Mayer A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome Arch Intern Med 161 2001 1733 1740 (Pubitemid 32679548)
3. F. Cremonini, S. Delgado-Aros, and M. Camilleri Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials Neurogastroenterol Motil 15 2003 79 86 (Pubitemid 36313138)
4. S.P. Dunlop, N. Coleman, and A.C. Perkins Decreased post-prandial 5HT in constipation predominant irritable bowel syndrome (abstr) Gastroenterology 124 2003 A-136
5. S.P. Dunlop, N.S. Coleman, and E. Blackshaw Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome Clin Gastroenterol Hepatol 3 2005 349 357 (Pubitemid 40488343)
6. W. Atkinson, S. Lockhart, and P.J. Whorwell Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome Gastroenterology 130 2006 34 43 (Pubitemid 43049833)
7. A. McIntyre, R.M. Vincent, and A.C. Perkins Effect of bran, ispaghula, and inert plastic particles on gastric emptying and small bowel transit in humans: the role of physical factors Gut 40 1997 223 227 (Pubitemid 27093098)
8. N.S. Coleman, S. Foley, and S.P. Dunlop Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease Clin Gastroenterol Hepatol 4 2006 874 881 (Pubitemid 43994540)
9. D.S. Sanders, M.J. Carter, and D.P. Hurlstone Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care Lancet 358 2001 1504 1508 (Pubitemid 33055702)
10. S. Foley, N. Coleman, and G.K.T. Holmes Serotonin transporter expression is reduced in celiac disease (abstr) Gastroenterology 130 2006 A740
11. R.K. Gill, N. Pant, and S. Saksena Function, expression, and characterization of the serotonin transporter in the native human intestine Am J Physiol Gastrointest Liver Physiol 294 2008 G254 G262
12. R. Spiller, and A. Bennett Searching for the answer to irritable bowel syndrome in the colonic mucosa: SERTainty and unSERTainty Gastroenterology 132 2007 437 441 (Pubitemid 46108772)
13. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatr Scand 67 1983 361 370 (Pubitemid 13098606)
14. N.J. Talley, S.F. Phillips, and C.M. Wiltgen Assessment of functional gastrointestinal disease: the bowel disease questionnaire Mayo Clin Proc 65 1990 1456 1479
15. K.W. Heaton, J. Radvan, and H. Cripps Defecation frequency and timing, and stool form in the general population: a prospective study Gut 33 1992 818 824
16. S.P. Dunlop, D. Jenkins, and R.C. Spiller Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome Am J Gastroenterol 98 2003 1578 1583 (Pubitemid 36875351)
17. M.G. Buckley, S. Variend, and A.F. Walls Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in Sudden Infant Death Syndrome (SIDS) An investigation of anaphylactic mechanisms Clin Exp Allergy 31 2001 1696 1704 (Pubitemid 34204426)
18. M.D. Coates, C.R. Mahoney, and D.R. Linden Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome Gastroenterology 126 2004 1657 1664 (Pubitemid 38736329)
19. U. Wahnschaffe, R. Ullrich, and E.O. Riecken Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome Gastroenterology 121 2001 1329 1338 (Pubitemid 33140450)
20. R.C. Spiller Role of infection in irritable bowel syndrome J Gastroenterol 42 Suppl 17 2007 41 47 (Pubitemid 46140363)
21. T. Liebregts, B. Adam, and C. Bredack Immune activation in patients with irritable bowel syndrome Gastroenterology 132 2007 913 920 (Pubitemid 46440872)
22. L. O'Mahony, J. McCarthy, and P. Kelly Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles Gastroenterology 128 2005 541 551 (Pubitemid 40585355)
23. T.G. Dinan, E.M. Quigley, and S.M. Ahmed Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130 2006 304 311 (Pubitemid 43202030)
24. G.F. Longstreth, W.G. Thompson, and W.D. Chey Functional bowel disorders Gastroenterology 130 2006 1480 1491
25. G. Ragnarsson, and G. Bodemar Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS) Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study Eur J Gastroenterol Hepatol 10 1998 415 421 (Pubitemid 28241429)
26. M. Guilarte, J. Santos, and I. de Torres Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum Gut 56 2007 203 209
27. G. Barbara, V. Stanghellini, R. De Giorgio, C. Cremon, G.S. Cottrell, D. Santini, and G. Pasquinelli Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome Gastroenterology 126 2004 693 702 (Pubitemid 38298317)
28. J. Santos, E. Saperas, and C. Nogueiras Release of mast cell mediators into the jejunum by cold pain stress in humans Gastroenterology 114 1998 640 648 (Pubitemid 28160398)
29. R. Roka, J. Demaude, and N. Cenac Colonic luminal proteases activate colonocyte proteinase-activated receptor-2 and regulate paracellular permeability in mice Neurogastroenterol Motil 19 2007 57 65 (Pubitemid 44952779)
30. G. Barbara, B. Wang, and V. Stanghellini Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome Gastroenterology 132 2007 26 37 (Pubitemid 46108761)
31. N. Cenac, C.N. Andrews, and M. Holzhausen Role for protease activity in visceral pain in irritable bowel syndrome J Clin Invest 117 2007 636 647 (Pubitemid 46348522)
32. S.H. Wang, L. Dong, and J.Y. Luo Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome World J Gastroenterol 13 2007 6041 6047 (Pubitemid 350238273)
33. D.R. Linden, J.X. Chen, and M.D. Gershon Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis Am J Physiol Gastrointest Liver Physiol 285 2003 G207 G216
34. J.R. O'Hara, W. Ho, and D.R. Linden Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis Am J Physiol Gastrointest Liver Physiol 287 2004 G998 G1007
35. J. Wheatcroft, D. Wakelin, and A. Smith Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction Neurogastroenterol Motil 17 2005 863 870 (Pubitemid 41748282)
36. C. Keating, M. Beyak, and S. Foley Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism J Physiol 586 2008 4517 4530
37. K.F. Foley, C. Pantano, and A. Ciolino IFN-gamma and TNF-alpha decrease serotonin transporter function and expression in Caco2 cells Am J Physiol Gastrointest Liver Physiol 292 2007 G779 G784
38. M. Camilleri, C.N. Andrews, and A.E. Bharucha Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome Gastroenterology 132 2007 17 25 (Pubitemid 46108754)
39. Y. Meier, J.J. Eloranta, and J. Darimont Regional distribution of solute carrier mRNA expression along the human intestinal tract Drug Metab Dispos 35 2007 590 594 (Pubitemid 46513261)
40. A.P. Kerckhoffs, J.J. Ter Linde, and L.M. Akkermans Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients Neurogastroenterol Motil 20 2008 900 907 (Pubitemid 352019709)
41. R.D. Blakely, S. Ramamoorthy, and S. Schroeter Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins Biol Psychiatry 44 1998 169 178 (Pubitemid 28378299)
42. M.D. Gershon Review article: serotonin receptors and transportersroles in normal and abnormal gastrointestinal motility Aliment Pharmacol Ther 20 Suppl 7 2004 3 14 (Pubitemid 39657670)
43. R. Mossner, and K.P. Lesch Role of serotonin in the immune system and in neuroimmune interactions Brain Behav Immun 12 1998 249 271 (Pubitemid 29224829)
44. S.A. Boehme, F.M. Lio, and L. Sikora Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin J Immunol 173 2004 3599 3603 (Pubitemid 39280718)
45. A.M. Piliponsky, G.J. Gleich, and A. Nagler Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor Blood 101 2003 1898 1904 (Pubitemid 36237591)
46. C.C. Walline, D.E. Nichols, and F.I. Carroll Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition J Pharmacol Exp Ther 325 2008 791 800 (Pubitemid 351724338)
47. A. Van Gossum, O. Dewit, and E. Louis Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection Inflamm Bowel Dis 13 2007 135 142 (Pubitemid 46806221)
48. M. Kim, F.L. Christofi, and J. Xue Mechanically evoked 5-hydroxytryptamine release is mediated by caveolin-associated cholesterol rich membrane domains Neurogastroenterol Motil 19 2007 309 317 (Pubitemid 46474792)
49. M. Kim, N.H. Javed, and F.L. Christofi Adenosine acts at A1, A2A and A2B receptors to modulate 5-Hydroxytryptamine release from human BON cells (abstr) Gastroenterology 118 2000 A306
50. A. Radonic, S. Thulke, and I.M. Mackay Guideline to reference gene selection for quantitative real-time PCR Biochem Biophys Res Commun 313 2004 856 862 (Pubitemid 38050071)